1. The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease. Issue 8 (23rd March 2017) Authors: Rouzade‐Dominguez, M.‐L.; Pezous, N.; David, O. J.; Tutuian, R.; Bruley des Varannes, S.; Tack, J.; Malfertheiner, P.; Allescher, H.‐D.; Ufer, M.; Rühl, A. Journal: Neurogastroenterology & motility Issue: Volume 29:Issue 8(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗